Simon Archibald, PhD joined Integra in 1997 as Senior Director of Neurological Programs to oversee the clinical and commercial development of the NeuraGen nerve guide system and to explore the development of a neurosurgical product line from the existing Integra collagen business and patent portfolio. In 1997 he initiated the program that resulted in the development of the DuraGen dural graft matrix for which he is a co-inventor. In 1999 he was promoted to vice President of R&D for the new Integra NeuroSciences business and in 2001 he was promoted to Vice President of Clinical Affairs. Previously, he was an Assistant Professor in the Department of Neurosurgery at Duke University Medical Center, to which he was appointed after completing his Research Fellowship in the Department of Neuropathology and Neuroscience at Harvard Medical School. He graduated with a degree in Zoology from the University of Reading in the UK, and has a PhD in Biomedical Engineering from the University of North Staffordshire in the UK. His primary research focus is in peripheral and central nervous system regeneration with a particular emphasis of translating discoveries in the basic sciences to clinical practice.